Acetyl-l-carnitine protects striatal neurons against in vitro ischemia: The role of endogenous acetylcholine

Neuropharmacology

Volumn 50, Issue 8, 2006, Pages 917-923

  Picconi, Barbara ^a   Barone, Ilaria ^a   Pisani, Antonio ^b   Nicolai, Raffaella ^c   Benatti, Paola ^c   Bernardi, Giorgio ^a,b   Calvani, Menotti ^c   Calabresi, Paolo ^a,d  

^a IRCCS FONDAZIONE SANTA LUCIA   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

^c Sigma Tau SpA   (Italy)

^d UNIVERSITY OF PERUGIA   (Italy)

Author keywords

Electrophysiology; Field potentials; Ischemia; Mitochondrial metabolism; Neuroprotection; Striatum

Indexed keywords

ACETYLCHOLINE; GLUCOSE; HEMICHOLINIUM 3; LEVACECARNINE; METHOCTRAMINE; MUSCARINIC M1 RECEPTOR ANTAGONIST; MUSCARINIC M2 RECEPTOR ANTAGONIST; MUSCARINIC RECEPTOR BLOCKING AGENT; NITROGEN; OXYGEN; PIRENZEPINE; SCOPOLAMINE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN ISCHEMIA; BRAIN NERVE CELL; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORPUS STRIATUM; DRUG INHIBITION; DRUG MECHANISM; ELECTRIC POTENTIAL; ELECTROPHYSIOLOGY; HYPOXIC CELL; IN VITRO STUDY; MODEL; NERVE POTENTIAL; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; STARVATION;

ACETYLCARNITINE; ACETYLCHOLINE; ANIMALS; CHOLINERGIC AGENTS; DIAMINES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; EVOKED POTENTIALS; HEMICHOLINIUM 3; ISCHEMIA; MUSCARINIC ANTAGONISTS; NEURONS; NOOTROPIC AGENTS; PARASYMPATHOLYTICS; PIRENZEPINE; RATS; RATS, WISTAR; SCOPOLAMINE; VISUAL CORTEX;

EID: 33646899542     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2006.01.002     Document Type: Article

References (49)

1. Ando S., Tadenuma T., Tanaka Y., Fukui F., Kobayashi S., Ohashi Y., and Kawabata T. Enhancement of learning capacity and cholinergic synaptic function by carnitine in aging rats. J. Neurosci. Res. 66 (2001) 266-271
2. Aureli T., Miccheli A., Di Cocco M.E., Ghirardi O., Giuliani A., Ramacci M.T., and Conti F. Effect of acetyl-l-carnitine on recovery of brain phosphorus metabolites and lactic acid level during reperfusion after cerebral ischemia in the rat - study by 13P- and 1H-NMR spectroscopy. Brain Res. 643 (1994) 92-99
3. Badini I., Beani L., Bianchi C., Marzola G., and Siniscalchi A. Post-ischemic recovery of acetylcholine release in vitro: influence of different excitatory amino acid receptor subtype antagonists. Neurochem. Int. 31 (1997) 817-824
4. Beal M.F. Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses?. Ann. Neurol. 31 (1992) 119-130
5. Bellingham M.C., and Berger A.J. Presynaptic depression of excitatory synaptic inputs to rat hypoglossal motoneurons by muscarinic M2 receptors. J. Neurophysiol. 76 (1996) 3758-3770
6. Bieber L.L. Carnitine. Annu. Rev. Biochem. 57 (1988) 261-283
7. Burlina A.P., Sershen H., Debler E.A., and Lajtha A. Uptake of acetyl-l-carnitine in the brain. Neurochem. Res. 14 (1989) 489-493
8. Calabresi P., Pisani A., Mercuri N.B., and Bernardi G. On the mechanisms underlying hypoxia-induced membrane depolarization in striatal neurons. Brain 118 (1995) 1027-1038
9. Calabresi P., Centonze D., Pisani A., Sancesario G., Gubellini P., Marfia G.A., and Bernardi G. Striatal spiny neurons and cholinergic interneurons express differential ionotropic glutamatergic responses and vulnerability: implications for ischemia and Huntington's disease. Ann. Neurol. 43 (1998) 586-597
10. Calabresi P., Centonze D., and Bernardi G. Cellular factors controlling neuronal vulnerability in the brain: a lesson from the striatum. Neurology 55 (2000) 1249-1255
11. Calabresi P., Centonze D., Gubellini P., Pisani A., and Bernardi G. Acetylcholine-mediated modulation of striatal function. Trends Neurosci. 23 (2000) 120-126
12. Calabresi P., Picconi B., Saulle E., Centonze D., Hainsworth A.H., and Bernardi G. Is pharmacological neuroprotection dependent on reduced glutamate release?. Stroke 31 (2000) 766-772
13. Calabresi P., Saulle E., Centonze D., Pisani A., Marfia G.A., and Bernardi G. Post-ischaemic long-term synaptic potentiation in the striatum: a putative mechanism for cell type-specific vulnerability. Brain 125 (2002) 844-860
14. Calabresi P., Centonze D., Cupini L.M., Costa C., Pisani F., and Bernardi G. Ionotropic glutamate receptors: still a target for neuroprotection in brain ischemia? Insights from in vitro studies. Neurobiol. Dis. 12 (2003) 82-88
15. Calabresi P., Centonze D., Pisani A., Cupini L., and Bernardi G. Synaptic plasticity in the ischaemic brain. Lancet Neurol 2 (2003) 622-629
16. Calabresi P., Marti M., Picconi B., Saulle E., Costa C., Centonze D., Pisani F., and Bernardi G. Lamotrigine and remacemide protect striatal neurons against in vitro ischemia: an electrophysiological study. Exp. Neurol. 182 (2003) 461-469
17. Calvani M., and Arrigoni-Martelli E. Attenuation by acetyl-l-carnitine of neurological damage and biochemical derangement following brain ischemia and reperfusion. Int. J. Tissue React. 21 (1999) 1-6
18. Centonze D., Saulle E., Pisani A., Bernardi G., and Calabresi P. Adenosine-mediated inhibition of striatal GABAergic synaptic transmission during in vitro ischaemia. Brain 124 (2001) 1855-1865
19. Costa C., Leone G., Saulle E., Pisani F., Bernardi G., and Calabresi P. Coactivation of GABA(A) and GABA(B) receptor results in neuroprotection during in vitro ischemia. Stroke 35 (2004) 596-600
20. Curti D., Dagani F., Galmozzi M.R., and Marzatico F. Effect of aging and acetyl-l-carnitine on energetic and cholinergic metabolism in rat brain regions. Mech. Ageing Dev. 47 (1989) 39-45
21. Dhitavat S., Ortiz D., Shea T.B., and Rivera E.R. Acetyl-l-carnitine protects against amyloid-beta neurotoxicity: roles of oxidative buffering and ATP levels. Neurochem. Res. 27 (2002) 501-505
22. Dolezal V., and Tucek S. Utilization of citrate, acetylcarnitine, acetate, pyruvate and glucose for the synthesis of acetylcholine in rat brain slices. J. Neurochem. 36 (1981) 1323-1330
23. Duchen M.R. Mitochondria in health and disease: perspectives on a new mitochondrial biology. Mol. Aspects Med. 25 (2004) 365-451
24. Fariello R.G., Ferraro T.N., Golden G.T., and DeMattei M. Systemic acetyl-l-carnitine elevates nigral levels of glutathione and GABA. Life Sci. 43 (1988) 289-292
25. Ghelardini C., Galeotti N., Nicolodi M., Donaldson S., Sicuteri F., and Bartolini A. Involvement of central cholinergic system in antinociception induced by sumatriptan in mouse. Int. J. Clin. Pharmacol. Res. 17 (1997) 105-109
26. Ghelardini C., Galeotti N., Calvani M., Mosconi L., Nicolai R., and Bartolini A. Acetyl-l-carnitine induces muscarinic antinociception in mice and rats. Neuropharmacology 43 (2002) 1180-1187
27. Greene J.G., and Greenamyre J.T. Bioenergetics and glutamate excitotoxicity. Prog. Neurobiol. 48 (1996) 613-634
28. Hagen T.M., Ingersoll R.T., Wehr C.M., Lykkesfeldt J., Vinarsky V., Bartholomew J.C., Song M.H., and Ames B.N. Acetyl-l-carnitine fed to old rats partially restores mitochondrial function and ambulatory activity. Proc. Natl. Acad. Sci. U.S.A. 95 (1998) 9562-9566
29. Hunter A.J., Green A.R., and Cross A.J. Animal models of acute ischaemic stroke: can they predict clinically successful neuroprotective drugs?. Trends Pharmacol. Sci. 16 (1995) 123-128
30. Imperato A., Ramacci M.T., and Angelucci L. Acetyl-l-carnitine enhances acetylcholine release in the striatum and hippocampus of awake freely moving rats. Neurosci. Lett. 107 (1989) 251-255
31. Ishimaru H., Takahashi A., Ikarashi Y., and Maruyama Y. Effects of MK-801 and pentobarbital on cholinergic terminal damage and delayed neuronal death in the ischemic gerbil hippocampus. Brain Res. Bull. 43 (1997) 81-85
32. Iwasaki K., Kitamura Y., Ohgami Y., Mishima K., and Fujiwara M. The disruption of spatial cognition and changes in brain amino acid, monoamine and acetylcholine in rats with transient cerebral ischemia. Brain Res. 709 (1996) 163-172
33. Janiri L., Falcone M., Persico A., and Tempesta E. Activity of l-carnitine and l-acetylcarnitine on cholinoceptive neocortical neurons of the rat in vivo. J. Neural Transm. Gen. Sect. 86 (1991) 135-146
34. Kristian T. Metabolic stages, mitochondria and calcium in hypoxic/ischemic brain damage. Cell Calcium 36 (2004) 221-233
35. Lee J.M., Zipfel G.J., and Choi D.W. The changing landscape of ischaemic brain injury mechanisms. Nature 399 (1999) A7-A14
36. Liu J., Evans M.S., and Lee T.J. Presynaptic muscarinic M(2)-receptor-mediated inhibition of N-type Ca(2+) channels in cultured sphenopalatine ganglion: direct evidence for acetylcholine inhibition of cerebral nitrergic neurogenic vasodilation. J. Pharmacol. Exp. Ther. 302 (2002) 397-405
37. Liu J., Killilea D.W., and Ames B.N. Age-associated mitochondrial oxidative decay: improvement of carnitine acetyltransferase substrate-binding affinity and activity in brain by feeding old rats acetyl-l-carnitine and/or R-alpha-lipoic acid. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 1876-1881
38. Lolic M.M., Fiskum G., and Rosenthal R.E. Neuroprotective effects of acetyl-l-carnitine after stroke in rats. Ann. Emerg. Med. 29 (1997) 758-765
39. Meldrum B.S. Update on the mechanism of action of antiepileptic drugs. Epilepsia 37 (1996) S4-S11
40. Nicotera P., and Lipton S.A. Excitotoxins in neuronal apoptosis and necrosis. J. Cereb. Blood Flow Metab. 19 (1999) 583-591
41. Onofrj M., Bodis-Wollner I., and Calvani M. Effect of l-acetyl carnitine HCl on rat steady-state visual evoked potentials. Comparison with l-carnitine. Drugs Exp. Clin. Res. 13 (1987) 5-13
42. Paradies G., Ruggiero F.M., Petrosillo G., Gadaleta M.N., and Quagliariello E. Effect of aging and acetyl-l-carnitine on the activity of cytochrome oxidase and adenine nucleotide translocase in rat heart mitochondria. FEBS Lett. 350 (1994) 213-215
43. Rapoport S.I. In vivo fatty acid incorporation into brain phospholipids in relation to signal transduction and membrane remodeling. Neurochem. Res. 24 (1999) 1403-1415
44. Rosenthal R.E., Williams R., Bogaert Y.E., Getson P.R., and Fiskum G. Prevention of postischemic canine neurological injury through potentiation of brain energy metabolism by acetyl-l-carnitine. Stroke 23 (1992) 1312-1317
45. Shuaib A., Waqaar T., Wishart T., Kanthan R., and Howlett W. Acetyl-l-carnitine attenuates neuronal damage in gerbils with transient forebrain ischemia only when given before the insult. Neurochem. Res. 20 (1995) 1021-1025
46. Shug A.L., Schmidt M.J., Golden G.T., and Fariello R.G. The distribution and role of carnitine in the mammalian brain. Life Sci. 31 (1982) 2869-2874
47. Spagnoli A., Lucca U., Menasce G., Bandera L., Cizza G., Forloni G., Tettamanti M., Frattura L., Tiraboschi P., and Comelli M. Long-term acetyl-l-carnitine treatment in Alzheimer's disease. Neurology 41 (1991) 1726-1732
48. Sugita S., Uchimura N., Jiang Z.G., and North R.A. Distinct muscarinic receptors inhibit release of gamma-aminobutyric acid and excitatory amino acids in mammalian brain. Proc. Natl. Acad. Sci. U.S.A. 88 (1991) 2608-2611
49. White H.L., and Scates P.W. Acetyl-l-carnitine as a precursor of acetylcholine. Neurochem. Res. 15 (1990) 597-601